Drug Trial Radar · NCT00047775
African-American Heart Failure Trial
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,100
Actual
Start
May 2001
Primary completion
Not stated
Study completion Aug 2004
Sponsor
- Lead sponsor
- NitromedIndustry
- Sponsor type
- Industry
- First posted
- Oct 21, 2002
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.
Conditions
- Congestive Heart Failure
Interventions
BiDilDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Cooper Green Hospital
Birmingham, Alabama
Cardiology and Medicine Clinic
Little Rock, Arkansas
Howard University Hospital
Washington D.C., District of Columbia
Miami International Cardiology Consultants
Aventura, Florida
Boston Medical Center
Boston, Massachusetts
Minneapolis VA Medical Center
Minneapolis, Minnesota
Saint Vincents Hospital and Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.